Luke Winchester from Merewether Capital reviews how Global Health grew its revenue by 25% despite COVID-19 limitations in FY21 and how it’s best-in-class product is set to disrupt the market.
Global Health is an Australian public-listed company (ASX: GLH) with a comprehensive portfolio of healthcare software applications directed at “Connecting Clinicians and Consumers”.
Our digital health technology solutions are strongly focussed on patient engagement and connectivity across the sector.
